Tag: Biktarvy

Gilead’s Biktarvy reinforced as a treatment option for HIV

by Jen Brogan | Oct 19, 2023 | News | 0

HIV affects approximately 39 million people worldwide and can lead to AIDS

Gilead’s HIV therapy Biktarvy demonstrates long-term sustained efficacy

by Lucy Parsons | Mar 8, 2021 | News | 0

Data from two Phase III studies demonstrated durable viral suppression in HIV-1 patients

Four new medicines available via NHS Scotland

by Selina McKee | Sep 11, 2018 | News | 0

The Scottish Medicines Consortium has cleared funds for use of four new medicines by NHS Scotland, including Sanofi’s biologic Dupixent for dermatitis.

Three medicines step closer to EU approval

by Selina McKee | Apr 30, 2018 | News | 0

Three medicines treating HIV, pain and cancer have been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) at its latest meeting.